BASEC ID Project title Type of project Type of clinical trial Study phase (clinical trials only) multi- / monocentric Category Principal investigator Sponsor Investigational sites Lead EC Local EC(s) Approval date Minors Study Ended
2015-00010 Cytokine Clearance with Cytoabsorbant Device during Cardiac Bypass: a Pilot Study clinical trial medical devices monocentric A Dr Antoine Schneider CHUV CHUV, Lausanne
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 12.04.2016 Study has ended
2015-00011 Diagnostic performance of an automated breast ultrasound system (ABUS): a single centre study clinical trial medical devices monocentric A PD Dr. med. Dr. sc. hum. Andreas Boss Institut für Interventionelle und diagnostische Radiologie USZ Institut für Interventionelle und diagnostische Radiologie USZ , Zürich
Kantonale Ethikkommission Zürich 12.01.2016
2015-00012 Mixed methods study to test the efficacy of the adapted German PRO-SELF© Plus Pain Control Program, an intervention directed at outpatients with cancer and their family caregivers to reduce pain and r More ... clinical trial other clinical trials multicentric A PD Dr. Elisabeth Spichiger University Basel, Medical Faculty, Institute of Nursing Science University Basel, Medical Faculty, Institute of Nursing Science, Basel
Inselspital Bern, University Hospital, Department of Nursing/MTT, Bern
University Hospital Zurich, Center Clinical Nursing Scienc More ...
Ethikkommission Nordwest- und Zentralschweiz EKNZ Kantonale Ethikkommission Bern, Kantonale Ethikkommission Zürich 29.03.2016 Study has ended
2015-00015 Endocrine and emotional effects of lisdexamfetamine and d-amphetamine: a placebo-controlled study in healthy subjects (LisDexStudy) clinical trial drugs phase 1 monocentric C Prof. Dr. med. Matthias Liechti University Hospital Basel University Hospital Basel, Basel
Ethikkommission Nordwest- und Zentralschweiz EKNZ 23.12.2015 Study has ended
2015-00020 SINGLE CENTER, OPEN-LABEL, PROSPECTIVE STUDY TO CHARACTERIZE THE PHARMACOKINETICS OF METAMIZOLE AND ITS METABOLITES FOLLOWING INTRAVENOUS ADMINISTRATION IN CHILDREN LESS THAN 6 YEARS OLD clinical trial drugs phase 2 monocentric B Prof. Marc Pfister University of Basel Children s Hospital University of Basel Childrens Hospital, Basel
Ethikkommission Nordwest- und Zentralschweiz EKNZ 05.01.2016 yes Study has ended
2015-00023 GS-US-326-1100: A Combined Phase 2/3, Double-Blind, Randomized, Placebo-Controlled, Induction and Maintenance Study Evaluating the Safety and Efficacy of GS-5745 in Subjects with Moderately to Severel More ... clinical trial drugs phase 2 multicentric C Prof. Dr Gerhard Rogler Gilead Sciences USZ, Zürich
Gastroenterologische Praxis Balsiger, Seibold & Partner, Bern
USB Gastroenterologie und Hepathologie , Basel
Kantonale Ethikkommission Zürich Ethikkommission Nordwest- und Zentralschweiz EKNZ, Kantonale Ethikkommission Bern 18.03.2016 Study has ended
2015-00024 Effects of empagliflozin an SGLT2-inhibitor on healthy volunteers with induced hypotonic hyponatremia - the DIVE-study clinical trial drugs n/a monocentric C Prof / Mirjam / Christ Endokrinologie, Universitätsspital Basel Endocrinology , Basel
Ethikkommission Nordwest- und Zentralschweiz EKNZ 08.01.2016 Study has ended
2015-00031 Double-blind, randomized, placebo-controlled, phase III study on the efficacy and tolerability of a 48-week treatment with two different doses of budesonide effervescent tablets vs. placebo for mainte More ... clinical trial drugs phase 3 multicentric C Dr. med. Alain Schoepfer Dr. Falk Pharma GmbH University Hospital Lausanne/CHUV Division of Gastroenterology and Hepatology, Lausanne
Praxis für Gastroenterologie, Römerstraße 7, CH-4600 Olten
Universitätsklinik Basel Abteilung für Gastroenterolo More ...
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) Ethikkommission Nordwest- und Zentralschweiz EKNZ, Kantonale Ethikkommission Zürich 25.05.2016 Study has ended
2015-00032 The effect of biopolymer based lipid emulsions on GI function, GI peptide response
and satiation in healthy volunteers; a randomized, double blind, unbalanced threeway crossover study.
clinical trial other clinical trials monocentric B Dr. Andreas Setingoetter University Hospital Zurich University Hospital Zurich, Zurich
Kantonale Ethikkommission Zürich 01.04.2016 Study has ended
2015-00033 A Phase I/II, multicenter, open-label, dose-escalation study of the safety and pharmacokinetics of cobimetinib in pediatric and young adult patients with previously treated solid tumors clinical trial drugs phase 1 monocentric C Dr. Nicolas Gerber F. Hoffmann-La Roche Ltd. Universitäts-Kinderspital, Zürich
Kantonale Ethikkommission Zürich 15.07.2016 yes Study has ended
2015-00034 Prevalence of HPV infection using self-sampling screening and monitoring the Earlier Impact of HPV-Vaccination Program in Switzerland clinical trial medical devices monocentric A Prof Patrick Petignat Geneva university hospital Hopital universitaire de Geneve, geneva
Commission Cantonale d'éthique de la recherche Genève (CCER) 05.01.2016 Study has ended
2015-00039 BIOTRONIK – Safety and clinical performance of the self-expanding transcatheter BIOVALVE prosthesis in subjects with severe symptomatic calcified aortic valve stenosis suitable for transfemoral transc More ... clinical trial medical devices monocentric C2 Prof. Robert Bauernschmitt BIOTRONIK AG - Clinical Affairs UniversitätsSpital Zürich - Klinik für Herz- und Gefässchirurgie, Zürich
Kantonale Ethikkommission Zürich 08.03.2016 Study has ended
2015-00040 A Phase 3, Double-Blind, Randomized, Long-Term, Placebo-Controlled,
Multicenter Study Evaluating the Safety and Efficacy of Obeticholic Acid in
Subjects with Nonalcoholic Steatohepatitis
clinical trial drugs phase 3 multicentric C Prof. Dr. Annalisa Berzigotti Intercept Pharmaceuticals Inc. University Clinic of Visceral Surgery and Medicine, Bern
Kantonsspital St. Gallen, St. Gallen
EPATOCENTRO TICINO, Lugano
USZ, University of Zurich, Zürich
Kantonale Ethikkommission Bern Ethikkommission Ostschweiz (EKOS), Kantonale Ethikkommission Zürich, Comitato etico cantonale Ticino 01.06.2016 Study has ended
2015-00042 SAKK 16/14
Anti-PD-L1 antibody MEDI4736 in addition to neoadjuvant chemotherapy in patients with stage IIIA(N2) non-small cell lung cancer (NSCLC). A multicenter single-arm phase II trial.
clinical trial drugs phase 2 multicentric C Dr. med. David König SAKK Universitätsspital Basel, Basel
Inselspital Bern, Bern
Spital STS AG Thun, Thun
Kantonspital Aarau, Aarau
Kantonsspital Baden, Baden
Luzerner Kantonsspital, Luzern
St. Claraspital, Basel
Hôpitaux Univ More ...
Ethikkommission Nordwest- und Zentralschweiz EKNZ Ethikkommission Nordwest- und Zentralschweiz EKNZ, Ethikkommission Ostschweiz (EKOS), Kantonale Ethikkommission Bern, Kantonale Ethikkommission Zürich, Commission cantonale d'Éthique de la Recherche s More ... 30.03.2016
2015-00043 M13-545: A Phase 3, Randomized, Double-Blind Study Comparing ABT-494 Once Daily Monotherapy to Methotrexate (MTX) Monotherapy in MTX-Naïve Subjects with Moderately to Severely Active Rheumatoid Arthri More ... clinical trial drugs phase 3 monocentric C Prof. Dr. Jean Dudler AbbVie AG Service de rhumatologie HFR Fribourg – Hôpital Cantonal, Fribourg
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) 14.03.2016 Study has ended
2015-00044 M13-549: A Phase III, Randomized, Double-Blind Study Comparing ABT-494 to Placebo in Subjects with Moderately to Severely Active Rheumatoid Arthritis Who Are on a Stable Dose of Conventional Synthetic More ... clinical trial drugs phase 3 multicentric C Prof. Dr. Jean Dudler AbbVie AG HFR Kantonsspital Freiburg, Rheumatologie, 1708 Freiburg
Kantonsspital Aarau, Abteilung Rheumatologie, Aarau
Commission cantonale d'Éthique de la Recherche sur l'être humain Vaud (CER-VD) Ethikkommission Nordwest- und Zentralschweiz EKNZ 23.02.2016 Study has ended
2015-00055 Assessment of psychological and metabolic responses during fructose intolerance breath tests in patients with functional GI disorders: placebo-controlled breath testing clinical trial other clinical trials monocentric A Dr. med Clive Wilder-Smith Brain-Gut Research Group/Gastroenterology Group Practice Brain-Gut-Research Group/Gastroenterology Group Practice, Bern
Kantonale Ethikkommission Bern 17.05.2016 Study has ended
2015-00057 GA29144 - A PHASE III, RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, MULTICENTER STUDY TO EVALUATE THE EFFICACY AND SAFETY OF
ETROLIZUMAB AS AN INDUCTION AND MAINTENANCE TREATMENT FOR PATIENTS WITH M More ...
clinical trial drugs phase 3 multicentric C Prof. Dr. Stephan Brand F. Hoffmann-La Roche Ltd. Kantonsspital St. Gallen, St. Gallen
Inselspital Bern, Bern
Crohn-Colitis Zentrum Bern, Bern
Universitätsspital Zürich, Zürich
Ethikkommission Ostschweiz (EKOS) Kantonale Ethikkommission Bern, Kantonale Ethikkommission Zürich 15.03.2016 Study has ended
2015-00059 Sienna+® Injection Time Pilot Study: A prospective observational multicentre, controlled clinical trial to evaluate the performance of superparamagnetic iron oxide vs. standard technique as tracer in More ... clinical trial medical devices multicentric A PD Dr. Cornelia Leo Kantonsspital Baden AG, Frauenklinik Kantonsspital Baden AG, Baden
Universitätsklinik für Frauenheilkunde, Inselspital, Bern
Ethikkommission Nordwest- und Zentralschweiz EKNZ Kantonale Ethikkommission Bern 05.10.2016
2015-00068 Responsiveness of the German Version of the Neck Disability Index (NDI-G) clinical trial other clinical trials monocentric A Dr. Jaap Swaneburg Balgrist University Clinic Balgrist University Clinic, Zurich
Kantonale Ethikkommission Zürich 28.01.2016 Study has ended